Next Generation Antithrombotic Therapy: Focus on Antisense Therapy against Coagulation Factor XI-Reference-Cited by-同舟云学术

Next Generation Antithrombotic Therapy: Focus on Antisense Therapy against Coagulation Factor XI

Published:2015-02-18 Issue:02 Volume:41 Page:255-262
ISSN:0094-6176
Container-title:Seminars in Thrombosis and Hemostasis
language:en
Short-container-title:Semin Thromb Hemost

Author:

Harenberg Job¹,Mattiuzzi Camilla²,Favaloro Emmanuel³,Lippi Giuseppe⁴

Affiliation:

1. Clinical Pharmacology, Medical Faculty Mannheim, Ruprecht-Karls University Heidelberg, Mannheim, Germany

2. Service of Clinical Governance, General Hospital of Trento, Trento, Italy

3. Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Pathology West, Westmead Hospital, Westmead, New South Wales, Australia

4. Laboratory of Clinical Chemistry and Hematology, Academic Hospital of Parma, Parma, Italy

Publisher

Georg Thieme Verlag KG

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0035-1546466.pdf

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factor XIa Inhibitors as a Novel Anticoagulation Target: Recent Clinical Research Advances;Pharmaceuticals;2023-06-11

2. Targeting the Contact Pathway of Coagulation for the Prevention and Management of Medical Device-Associated Thrombosis;Seminars in Thrombosis and Hemostasis;2023-04-12

3. Coming soon to a pharmacy near you? FXI and FXII inhibitors to prevent or treat thromboembolism;Hematology;2022-12-09

4. Factor XI, a potential target for anticoagulation therapy for venous thromboembolism;Frontiers in Cardiovascular Medicine;2022-10-31

5. Active FXI Can Independently Predict Ischemic Stroke in Anticoagulated Atrial Fibrillation Patients: A Cohort Study;Thrombosis and Haemostasis;2022-02-14